A detailed history of Credit Suisse Ag transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 35,958 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,958
Previous 34,931 2.94%
Holding current value
$0
Previous $563,000 0.36%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$13.58 - $17.36 $13,946 - $17,828
1,027 Added 2.94%
35,958 $565,000
Q4 2023

Feb 08, 2024

SELL
$10.11 - $16.54 $80,667 - $131,972
-7,979 Reduced 18.59%
34,931 $563,000
Q3 2023

Nov 13, 2023

SELL
$12.46 - $15.48 $234,335 - $291,132
-18,807 Reduced 30.47%
42,910 $545,000
Q2 2023

Aug 11, 2023

BUY
$13.28 - $15.96 $172,029 - $206,745
12,954 Added 26.57%
61,717 $868,000
Q1 2023

May 10, 2023

BUY
$14.26 - $22.1 $185,822 - $287,985
13,031 Added 36.47%
48,763 $753,000
Q4 2022

Feb 13, 2023

BUY
$14.85 - $19.04 $2,361 - $3,027
159 Added 0.45%
35,732 $585,000
Q3 2022

Nov 10, 2022

BUY
$12.38 - $20.23 $2,810 - $4,592
227 Added 0.64%
35,573 $658,000
Q2 2022

Aug 12, 2022

SELL
$9.11 - $13.98 $11,177 - $17,153
-1,227 Reduced 3.35%
35,346 $466,000
Q1 2022

May 16, 2022

BUY
$6.87 - $11.11 $10,978 - $17,753
1,598 Added 4.57%
36,573 $339,000
Q4 2021

Feb 14, 2022

BUY
$7.7 - $37.13 $3,110 - $15,000
404 Added 1.17%
34,975 $341,000
Q3 2021

Nov 12, 2021

BUY
$26.46 - $37.15 $62,260 - $87,413
2,353 Added 7.3%
34,571 $1.18 Million
Q2 2021

Aug 16, 2021

BUY
$32.73 - $47.95 $106,928 - $156,652
3,267 Added 11.28%
32,218 $1.18 Million
Q1 2021

May 14, 2021

SELL
$40.39 - $56.73 $1.7 Million - $2.39 Million
-42,057 Reduced 59.23%
28,951 $1.3 Million
Q4 2020

Feb 12, 2021

BUY
$51.77 - $66.18 $472,349 - $603,826
9,124 Added 14.74%
71,008 $4.05 Million
Q3 2020

Nov 13, 2020

SELL
$43.8 - $58.16 $505,320 - $670,991
-11,537 Reduced 15.71%
61,884 $3.18 Million
Q2 2020

Aug 12, 2020

BUY
$37.05 - $65.03 $1.97 Million - $3.45 Million
53,045 Added 260.33%
73,421 $4.39 Million
Q1 2020

May 13, 2020

SELL
$33.63 - $69.4 $321,704 - $663,880
-9,566 Reduced 31.95%
20,376 $839,000
Q4 2019

Feb 12, 2020

BUY
$31.7 - $69.93 $495,629 - $1.09 Million
15,635 Added 109.28%
29,942 $1.86 Million
Q3 2019

Nov 12, 2019

BUY
$19.95 - $38.85 $285,424 - $555,826
14,307 New
14,307 $486,000
Q3 2018

Nov 13, 2018

SELL
$33.57 - $42.1 $196,820 - $246,832
-5,863 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$20.06 - $44.95 $117,611 - $263,541
5,863 New
5,863 $230,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.